AU8008091A - Insulin analogues with organ preferential action - Google Patents

Insulin analogues with organ preferential action

Info

Publication number
AU8008091A
AU8008091A AU80080/91A AU8008091A AU8008091A AU 8008091 A AU8008091 A AU 8008091A AU 80080/91 A AU80080/91 A AU 80080/91A AU 8008091 A AU8008091 A AU 8008091A AU 8008091 A AU8008091 A AU 8008091A
Authority
AU
Australia
Prior art keywords
insulin analogues
preferential action
organ
organ preferential
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80080/91A
Inventor
Kirsten Drejer
Svend Havelund
Lauge Schaffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU8008091A publication Critical patent/AU8008091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU80080/91A 1990-07-02 1991-07-02 Insulin analogues with organ preferential action Abandoned AU8008091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK1583/90 1990-07-02
DK158390A DK158390D0 (en) 1990-07-02 1990-07-02 NEW PEPTIDES

Publications (1)

Publication Number Publication Date
AU8008091A true AU8008091A (en) 1992-01-23

Family

ID=8106283

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80080/91A Abandoned AU8008091A (en) 1990-07-02 1991-07-02 Insulin analogues with organ preferential action

Country Status (3)

Country Link
AU (1) AU8008091A (en)
DK (1) DK158390D0 (en)
WO (1) WO1992000322A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK33591D0 (en) * 1991-02-27 1991-02-27 Novo Nordisk As
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
DK2842576T3 (en) 2004-01-21 2017-10-16 Novo Nordisk Healthcare Ag Transglutaminase-mediated peptide conjugation
ES2601839T3 (en) 2006-09-22 2017-02-16 Novo Nordisk A/S Protease resistant insulin analogs
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
MX2010009850A (en) 2008-03-18 2010-09-30 Novo Nordisk As Protease stabilized, acylated insulin analogues.
US20160083448A1 (en) * 2013-03-15 2016-03-24 Case Western Reserve University Site 2 insulin analogues
RS57004B1 (en) 2013-10-07 2018-05-31 Novo Nordisk As Novel derivative of an insulin analogue
AU2015328222B9 (en) 2014-10-06 2020-12-24 Case Western Reserve University Biphasic single-chain insulin analogues
AU2017378102B2 (en) 2016-12-16 2022-10-13 Novo Nordisk A/S Insulin containing pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
EP0469084B1 (en) * 1989-04-20 1995-04-05 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues

Also Published As

Publication number Publication date
WO1992000322A1 (en) 1992-01-09
DK158390D0 (en) 1990-07-02

Similar Documents

Publication Publication Date Title
AU8054391A (en) Novel, protracted insulin analogues
ZA893508B (en) Insulin analogues
AU639126B2 (en) Oxorapamycin
AU9015891A (en) Animation
AU3162889A (en) Breach-cooled structure
AU8791591A (en) Tnf-muteins
AU7005591A (en) Agitators
AU624908B2 (en) Frame structure
AU7846991A (en) Aminobenzodiazepines
AU7583391A (en) Mechanical pencil
AU8008091A (en) Insulin analogues with organ preferential action
PL310007A1 (en) Insulin analogues
AU7804691A (en) N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas
AU7956191A (en) Transportsystem
AU2368892A (en) Igf-ii analogues
AU7726391A (en) Slitterscorer
AU7460591A (en) Point anchoring
AU8017991A (en) Structural elements
AU8740291A (en) 3d-spectacles
AU8723491A (en) Ornamental structure
GB9010233D0 (en) Amusements
AU7587991A (en) Electrodermatome
AU7446891A (en) Aquaculture
AU8311091A (en) Fin-fish farming
AU8984191A (en) Thiadiazinones